SciELO - Scientific Electronic Library Online

 
vol.46 número3Treating akathisia with pregabalin – A case report índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Archives of Clinical Psychiatry (São Paulo)

versão impressa ISSN 0101-6083versão On-line ISSN 1806-938X

Arch. Clin. Psychiatry (São Paulo) vol.46 no.3 São Paulo maio/jun. 2019  Epub 29-Jul-2019

https://doi.org/10.1590/0101-60830000000200 

Corrige o artigo: 10.1590/0101-60830000000189

Erratum

Erratum


Sex-differential effects of olanzapine vs. aripiprazole on glucose and lipid metabolism in first-episode schizophrenia

XUE-MEI ZHOU1

http://orcid.org/0000-0002-4774-4432

MAO-RONG HU2

http://orcid.org/0000-0002-8541-2893

MEI-YU GONG1

http://orcid.org/0000-0002-9092-3006

XUE-LIANG ZOU1

http://orcid.org/0000-0003-0688-1550

ZHI-MIN YU1

http://orcid.org/0000-0002-8732-4811

1Jiangxi Mental Health Centre, Nanchang, Jiangxi, China.

2 The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.

ZHou XM et al. / Arch Clin Psychiatry. 2019;46(2):33-9

Received: 06/29/2018 – Accepted: 04/02/2019

DOI: 10.1590/0101-60830000000189

On Table 4, where is written:

Table 4. The between-drug and within-drug evolution of the individual metabolic parameter over time in male patients with first-episode schizophrenia assigned to 12 weeks treatment with aripiprazole or olanzapine 

NBMI NTG
Baseline, female 0.41 (-0.05–0.88) -0.66 (-1.24–-0.09)
(The 4th weekend - Baseline), female 0.17 (0.01–0.32) 0.70 (0.22–1.18)
(The 8th weekend - Baseline), female 0.26 (0.11–0.42) 0.95 (0.47–1.43)
(The 12th weekend - Baseline), female 0.47 (0.32–0.63) 1.21 (0.73–1.69)
Baseline × (male - female) -0.40 (-1.06–0.26) 0.21 (-0.60–1.03)
The 4th weekend × (male - female) 0.08 (-0.13–0.30) 0 (-0.68–0.68)
The 8th weekend × (male - female) 0.21 (-0.01–-0.42) -0.07 (-0.74–0.61)
The 12th weekend × (male - female) 0.16 (-0.06–-0.38) 0.14 (-0.54–0.82)

Data are effect size (95% CI). The measurement units of all laboratory values for the fasting serum levels of lipids and glucose use mmol/L. All indicators are shown by their respective normal score. BMI: body mass index; TG: triglyceride.

It should be read:

Table 4. The between-drug and within-drug evolution of the individual metabolic parameter over time in male patients with first-episode schizophrenia assigned to 12 weeks treatment with aripiprazole or olanzapine 

NBMI NTG
Baseline, aripiprazole 0.41 (-0.05–0.88) -0.66 (-1.24–-0.09)
(The 4th weekend - Baseline), aripiprazole 0.17 (0.01–0.32) 0.70 (0.22–1.18)
(The 8th weekend - Baseline), aripiprazole 0.26 (0.11–0.42) 0.95 (0.47–1.43)
(The 12th weekend - Baseline), aripiprazole 0.47 (0.32–0.63) 1.21 (0.73–1.69)
Baseline × (olanzapine - aripiprazole) -0.40 (-1.06–0.26) 0.21 (-0.60–1.03)
The 4th weekend × (olanzapine - aripiprazole) 0.08 (-0.13–0.30) 0 (-0.68–0.68)
The 8th weekend × (olanzapine - aripiprazole) 0.21 (-0.01–-0.42) -0.07 (-0.74–0.61)
The 12th weekend × (olanzapine - aripiprazole) 0.16 (-0.06–-0.38) 0.14 (-0.54–0.82)

Data are effect size (95% CI). The measurement units of all laboratory values for the fasting serum levels of lipids and glucose use mmol/L. All indicators are shown by their respective normal score. BMI: body mass index; TG: triglyceride.

Address for correspondence: Xue-Mei Zhou. Jiangxi Mental Health Centre. 43 Shangfang Road, Qingshanhu District, 330029, Nanchang, Jiangxi, China. Telephone: 0086-13263912034. E-mail: xlf50@sina.com.cn

Creative Commons License  This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.